登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603882 证券简称：金域医学 公告编号：2026-007 广州金域医学检验集团股份有限公司 二、公司关注并核实的相关情况 针对公司股票异常波动，公司对有关事项进行了核查，并问询了控股股东、实际控制人及其一致行动 人，有关情况说明如下： （一）生产经营情况 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 公司股票交易连续三个交易日内（2026年1月8日、1月9日、1月12日）收盘价格涨幅偏离值累计超过 20%，根据《上海证券交易所交易规则》的有关规定，属于股票交易异常波动情形。 ● 经公司自查，并书面征询控股股东、实际控制人及其一致行动人，截至本公告披露日，除已在指定媒 体公开披露的信息外，确认不存在应披露而未披露的重大事项或重要信息。 ● 敬请广大投资者审慎投资、注意风险。 一、股票交易异常波动的具体情况 广州金域医学检验集团股份有限公司（以下简称"公司"）股票交易连续三个交易日内（2026年1月8日、 1月9日、1月12 ...

（编辑 任世碧） 证券日报网讯 1月12日，金域医学发布公告称，公司股票交易连续三个交易日内（2026年1月8日、1月9 日、1月12日）收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动情形。经公司自查，并书面 征询控股股东、实际控制人及其一致行动人，截至本公告披露日，除已在指定媒体公开披露的信息外， 确认不存在应披露而未披露的重大事项或重要信息。敬请广大投资者审慎投资、注意风险。 ...

公司股票交易连续三个交易日内（2026 年 1 月 8 日、1 月 9 日、1 月 12 日）收盘价格涨幅偏离值累计超过 20%，根据《上海证券交易所交易规则》的有 关规定，属于股票交易异常波动情形。 证券代码：603882 证券简称：金域医学 公告编号：2026-007 广州金域医学检验集团股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 经公司自查，并书面征询控股股东、实际控制人及其一致行动人，截至 本公告披露日，除已在指定媒体公开披露的信息外，确认不存在应披露而未披露 的重大事项或重要信息。 敬请广大投资者审慎投资、注意风险。 一、股票交易异常波动的具体情况 广州金域医学检验集团股份有限公司（以下简称"公司"）股票交易连续三 个交易日内（2026年1月8日、1月9日、1月12日）收盘价格涨幅偏离值累计超过 20%，根据《上海证券交易所交易规则》的有关规定，属于股票交易异常波动情 形。 二、公司关注并核实的相关情况 针对公司股票异常波动，公司对有关事项进行了核查，并问询了控 ...

关于《广州金域医学检验集团股份有限公司股票交易异常 波动有关事项的问询函》的回函 广州金域医学检验集团股份有限公司: 控股股东、实际控制人: 0 2026年1月12日 关于《广州金域医学检验集团股份有限公司股票交易异常 波动有关事项的问询函》的回函 一致行动人: 广州金域医学检验集团股份有限公司（以下简称"上市公司"） 发来的《广州金域医学检验集团股份有限公司股票交易异常波动有关 事项的问询函》已收悉。经自查核实,就有关事项回复如下: 本人作为上市公司的控股股东及实际控制人,截至目前,除已在 指定媒体公开披露的信息外,不存在影响上市公司股票价格异常波动 的重大事项,也不存在其他应披露而未披露的重大事项,包括但不限 于重大资产重组、股份发行、收购、债务重组、业务重组、资产剥离、 资产注入、股份回购、股权激励、破产重整、重大业务合作、引进战 略投资者等重大事项。 特此回复。 广州金域医学检验集团股份有限公司: 广州金域医学检验集团股份有限公司(以下简称"上市公 司")发来的《广州金域医学检验集团股份有限公司股票交易异常 波动有关事项的问询函》已收悉。经自查核实,就有关事项回复如 下: 本人作为上市公司的控股股东、 ...

Market Overview - The market showed strong fluctuations throughout the day, with all three major indices rising over 1%, and the Shanghai Composite Index achieving a 17-day consecutive rise [1] - AI application sectors experienced a significant surge, with stocks like BlueFocus and Hand Information hitting the daily limit [1] - The commercial aerospace concept continued its strong performance, with China Satellite and China Satcom both reaching new highs [1] - The brain-computer interface concept was also active, with stocks like DaoTech and Yanshan Technology hitting the daily limit [1] - Over 4,100 stocks in the Shanghai, Shenzhen, and Beijing markets rose, with a total transaction volume of 3.64 trillion, setting a new record for daily trading in A-shares [1] AI Marketing - The AI marketing concept saw a wave of limit-up stocks, including Gravity Media, Leo Holdings, and BoRui Communication [4] - Elon Musk announced on social media that he would open-source the latest content recommendation algorithm for the X platform within a week, interpreted by the market as his entry into the GEO space [4] - DeepSeek is set to release its next-generation flagship AI model, DeepSeek V4, in February, which reportedly outperforms major models like Anthropic Claude and OpenAI GPT series in programming capabilities [4][7] - Anthropic's Claude Code received a significant update, marking a new phase in global AI programming competition [4] Aerospace Sector - The aerospace sector continued to rise, with stocks like Luxin Investment, Goldwind Technology, and Daye Shares hitting the daily limit [10] - China applied for frequency resources for over 200,000 satellites, indicating a strategic national-level initiative [11] - Experts believe that the establishment of the Radio Innovation Institute will accelerate the 6G process, integrating satellite networks with ground communication networks [14] AI Medical - The AI medical sector also performed well, with companies like Meinian Health and Dean Diagnostics seeing consecutive gains [15] - OpenAI launched "ChatGPT Health," a health-related dialogue space that connects electronic medical records and health applications [15] - The demand for AI in healthcare is expected to grow significantly, driven by an aging population and an increase in chronic disease patients [18]

Group 1 - The core point of the article highlights that Kingmed Diagnostics has achieved a record trading volume of 1.189 billion yuan, the highest since February 21, 2025 [2] - The latest stock price of Kingmed Diagnostics has increased by 8.62%, with a turnover rate of 7.10% [2] - The previous trading day saw a total trading volume of 1.104 billion yuan for the stock [2] Group 2 - Kingmed Diagnostics was established on May 26, 2006, with a registered capital of 463.258275 million yuan [2]

从基金十大重仓股角度 1月12日，金域医学涨5.17%，截至发稿，报35.40元/股，成交4136.12万元，换手率0.25%，总市值 163.99亿元。 资料显示，广州金域医学检验集团股份有限公司位于广东省广州市国际生物岛螺旋三路10号，成立日期 2006年5月26日，上市日期2017年9月8日，公司主营业务涉及为全国超过23,000家各类医疗机构提供包 括理化质谱检验、基因组检验、病理诊断、生化发光检验、免疫学检验、其他综合检验等六大类合计近 80类检验技术,近3,200项检验项目的外包及科研技术服务。主营业务收入构成为：医学诊断服务 91.20%，销售诊断6.45%，其他1.47%，冷链物流服务0.62%，健康体检业务0.27%。 长城消费增值混合A（200006）成立日期2006年4月6日，最新规模5.16亿。今年以来收益17.29%，同类 排名26/9012；近一年收益40.7%，同类排名3084/8157；成立以来收益300.18%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考， ...

人民财讯1月9日电，据金域医学（603882）消息，1月9日，中山大学附属第三医院(简称"中山三院")、 金域医学和联通数智医疗联合打造的中山三院人工智能医生正式问世。据悉，这是基于真实住院病例与 完整诊疗路径进行推理的人工智能医生，在助力临床医生在提升诊疗效率的同时，也能推动更多高水平 医疗智慧和资源下沉到基层医疗一线。 ...

Core Insights - The AI healthcare sector is experiencing significant growth, with major healthcare ETFs, such as 512170, seeing a rise of over 2% in the first week of the year, indicating strong market interest [1] - OpenAI has launched ChatGPTHealth, a dedicated space for health-related conversations that integrates with electronic medical records and health applications, highlighting the increasing integration of AI in healthcare [2] - The global AI healthcare market is projected to grow from approximately $26.65 billion in 2024 to about $505.59 billion by 2033, with a compound annual growth rate (CAGR) of 38.8% [2] Market Performance - The largest healthcare ETF, 512170, recorded a trading volume exceeding 800 million yuan, reflecting robust investor engagement [1] - AI healthcare stocks led the market, with notable gains including a 13% increase in Weining Health and limit-up performances from Meinian Health and Kingmed Diagnostics [1] Investment Opportunities - Investors are encouraged to consider the healthcare ETF (512170) and its associated fund (012323), which includes 12 AI healthcare and brain-computer interface stocks, collectively accounting for over 36% of the index [2] - The current price-to-earnings ratio of the CSI Healthcare Index stands at 34.74, which is below the 39.22% percentile of the past decade, suggesting potential value for investors [2]

Core Viewpoint - The medical device sector is experiencing significant growth, with key stocks showing strong performance and substantial capital inflow into related ETFs, indicating a bullish market sentiment in this industry [1][4]. Group 1: Market Performance - The CSI All-Medical Device Index (H30217) rose by 1.59%, with notable stocks such as Di'an Diagnostics (300244) hitting a 20% limit up, and Kingmed Diagnostics (603882) reaching a 10% limit up [1]. - The largest medical device ETF (159883) saw a 1.53% increase, with over 260 million yuan in capital inflow during the afternoon session [1]. - Over the past four days, the medical device ETF has experienced continuous net inflows, totaling 1.232 billion yuan, with an average daily net inflow of 308 million yuan [1]. Group 2: Key Stock Movements - Di'an Diagnostics (300244) closed at 21.72 yuan, with a 20% increase and a transaction volume of 2.198 billion yuan [2]. - Anbiping (688393) rose by 15.33% to 31.83 yuan, with a transaction volume of 308 million yuan [2]. - Kingmed Diagnostics (603882) increased by 10% to 33.66 yuan, with a transaction volume of 1.086 billion yuan [2]. Group 3: Technological and Policy Developments - Shenzhen Hanyu Pharmaceutical and Huawei Cloud launched a "Peptide AI Process Optimization Assistant," reducing R&D cycles by 45% and improving decision-making efficiency by 90% [3]. - Guangzhou's new plan emphasizes biomedicine and health as a key emerging industry, aiming to build high-level innovation platforms around cell and gene technology [3]. - The Beijing action plan for 2026-2027 aims for widespread application of AI products in healthcare institutions by 2027 [3]. Group 4: ETF Characteristics - The medical device ETF (159883) has the highest brain-computer interface content in the market, accounting for over 23%, and is the largest ETF focused on the medical device sector [4]. - The ETF includes a strong representation of innovative domestic companies, with over 80% of its components from the Sci-Tech Innovation Board and the Growth Enterprise Market [4]. - The Hong Kong medical ETF (159366) tracks the CSI Hong Kong Stock Connect Medical Theme Index, providing exposure to high-quality assets in the medical sector [4].